464.1 | | Target | Disease | Hypotension | | | | | | |
Eotaxin-2/CCL24 | | Target | Disease | Psoriasis | | | | | | |
Des (1-6) IGF-II | | Target | Target | Urokinase-Type Plasminogen Activator | | | | | | |
Allopurinol (Zyloprim)- FDA | | Drug | Disease | Heart Disease | | | | | | |
5-Hydroxytryptamine 2b Receptor | | Target | Disease | Liver Disease | | | | | | |
5-Hydroxytryptamine 2b Receptor | | Target | Disease | Heart Disease | | | | | | |
Allopurinol (Zyloprim)- FDA | | Drug | Disease | Inflammation | | | | | | |
Allopurinol (Zyloprim)- FDA | | Drug | Disease | Leukemia | | | | | | |
5-Hydroxytryptamine 2b Receptor | | Target | Disease | Amyotrophic Lateral Sclerosis | | | | | | |
5-Hydroxytryptamine 2b Receptor | | Target | Target | Elastase | | | | | | |